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Development or progression of left ventricular hyper-
trophy has recently been described in children with hy-
pertrophic cardiomyopathy. To determine whether sim-
ilar changes in magnitude and distribution of left
ventricular hypertrophy may also occur in adult patients
with this disease, serial assessment of left ventricular
wall thickness was obtained with M-mode and two-di-
mensional echocardiography in 65 patients with hyper-
trophic cardiomyopathy who were 23 to 50 years of age.
The follow-up period was 3 to 6 years (mean 4).
None of the 65 patients showed a substantial increase
(2:5 mm) in left ventricular wall thickness; however, 9
(14%) demonstrated a substantial decrease (5 to 9 mm).
Wall thinning most commonly involved the anterior ven-
tricular septum (seven patients), but was also identified
in the posterior septum (six patients), lateral free wall
(two patients) and posterior free wall (one patient). In
the nine patients with wall thinning, left ventricular end-
Recent echocardiographic studies (I) have shown that the
magnitude and extent of left ventricular hypertrophy may
increase substantially during childhood in patients with hy-
pertrophic cardiomyopathy. However, it is not known whether
progression of left ventricular hypertrophy occurs in such
patients only during childhood, when body growth is most
accelerated, or whether it may also occur after mature body
size has been achieved. To address this question, we ob-
tained serial echocardiographic assessments of the extent of
left ventricular hypertrophy in a group of adult patients with
hypertrophic cardiomyopathy.
Methods
Selection and characterization of patients. Records of
the 445 patients with hypertrophic cardiomyopathy in whom
a two-dimensional echocardiogram was performed in the
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diastolic diameter increased significantly (from 44 ± 6
to 51 ± 6 mm; p < 0.001); however, in seven of the
nine, absolute cavity size remained within normal limits
(:552 mm) at the most recent evaluation. Eight of the
nine patients with left ventricular wall thinning and rel-
ative cavity enlargement were severely symptomatic and
one was mildly symptomatic.
In conclusion, substantial progression of left ventric-
ular hypertrophy was not identified in any of the study
patients. Hence, if such progression occurs in adults with
hypertrophic cardiomyopathy, it is probably rare. Con-
versely, an important minority of adult patients with
hypertrophic cardiomyopathy may show progressive left
ventricular wall thinning and relative cavity enlarge-
ment, which are usually associated with severe cardiac
symptoms.
(J Am Coli CardioI1987;9:1013-7)
echocardiography laboratory of the National Heart, Lung,
and Blood Institute during 1984 were reviewed, A total of
65 of the initial 445 patients met the following criteria and
therefore comprise the final study group: I) clinical and
echocardiographic follow-up of at least 3 years; 2) techni-
cally satisfactory echocardiograms permitting reliable as-
sessment of the magnitude and distribution of left ventricular
hypertrophy (2,3); and 3) age 220 and ::;50 years at the
time of the initial two-dimensional echocardiographic study,
We chose to exclude from this study patients older than 50
years of age, because coexistent systemic hypertension is
relatively common in older patients and could be an inde-
pendent cause of progression of left ventricular hypertrophy,
The diagnosis of'hypertrophic cardiomyopathy had been
established in each patient by the echocardiographic dem-
onstration of a nondilated hypertrophied left ventricle, in
the absence of another cardiac or systemic disease that could
produce left ventricular hypertrophy (4),
At the time of the most recent echocardiographic ex-
amination, the 65 study patients ranged in age from 23 to
50 years (mean 35); 39 patients (60%) were male, Sixteen
patients were asymptomatic, 28 had mild functional limi-
tation (New York Heart Association functional class II) and
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21 had moderate to severe limitation (functional classes III
and IV). The follow-up period was 3 to 6 years (mean 4).
During the period of observation, 12 of the 65 study patients
were taking no cardioactive medications, and the remaining
53 patients were treated with a beta-adrenergic blocking
agent (20 patients), verapamil (30 patients) or amiodarone
(3 patients); 8 patients were also receiving a diuretic.
Outflow tract obstruction and coronary artery dis-
ease. The magnitude of left ventricular outflow tract ob-
struction under basal conditions was assessed at cardiac
catheterization in 43 of the 65 patients and estimated from
the M-mode echocardiogram on the basis of the magnitude
and duration of systolic anterior motion of the mitral valve
in the other 22 patients (5,6). Left ventricular outflow tract
obstruction under basal conditions (gradient 2:30 mm Hg)
was considered to be present in 12 patients and was absent
in the other 53. Significant narrowing of the extramural
coronary arteries was excluded by coronary arteriography
in 7 of the II study patients who were >40 years of age;
coronary artery disease was considered unlikely in the re-
maining 4, because they were only mildly symptomatic and
had never experienced angina pectoris.
Two-dimensional echocardiography. A Varian (V-3000
or V-3400) real-time, phased array, ultrasound sector scan-
ner (80°) with a 2.25 MHz transducer, or an Advanced
Technology Laboratory (ATL) Mark 500 mechanical sector
scanner (84°) with a 3 MHz transducer were used to perform
the two-dimensional echocardiographic studies. Images were
recorded on I inch (2.54 ern) reel to reel videotape. Two-
dimensional echocardiograms obtained in each patient dur-
ing the initial and the most recent clinical evaluation were
sequentially rerecorded on a Hitachi HR-200B Format I
inch videotape recorder to allow serial review and immediate
comparison of the two studies. Each pair of echocardio-
grams was coded and measurements were obtained by one
observer who had no knowledge of the identity of the pa-
tients.
The two-dimensional echocardiographic images were ob-
tained in several cross-sectional planes using standard trans-
ducer positions (7). Changes in left ventricular wall thick-
ness were primarily assessed using the parasternal short-
axis planes (I); however, parasternal long-axis and apical
two and four chamber views were also utilized to integrate
the information obtained from the short-axis planes.
In the parasternal short-axis plane, the left ventricle was
divided into four regions: the anterior and posterior ven-
tricular septum and the lateral and posterior left ventricular
free walls (Fig. I) (3). Wall thickness of these four left
ventricular regions was evaluated during diastole at both the
mitral valve and the papillary muscle level. Wall thickness
was assessed directly from the television monitor with the
aid of calipers using a calibration scale produced by the
instrument. Location of endocardial and epicardial borders
was identified by viewing the pertinent portions of videotape
in slow-motion and real-time modes.
POSTERIOR VS
LATERAL
FREE WALL
Figure 1. Segments of left ventricular wall visualized by two-
dimensional echocardiography in the short-axisview, at the mitral
valve and papillary muscle levels. The points of insertion of the
right ventricle into the left ventricle are the anatomic landmarks
dividing the ventricular septum (VS) from the left ventricularfree
wall. A = anterior; L = left; P = posterior; R = right. (Repro-
duced with permission of the American Heart Association, Inc.
from Spirito et al. [3).)
In each patient, changes in left ventricular wall thickness
were assessed by comparing the same left ventricular seg-
ment in the initial and the most recent echocardiogram. Wall
thickness was considered to have changed when the same
left ventricular segment showed a difference in thickness of
2:5 mm between the two studies (I). This method of as-
sessing changes in left ventricular wall thickness in patients
with hypertrophic cardiomyopathy has been shown to have
guud reproducibility (I).
M-mode echocardiography. The M-mode echocardio-
grams were recorded with a 2.25 MHz unfocused Aerotech
transducer and an Hoffrel 101 ultrasound receiver interfaced
with a Honeywell 1856 strip chart recorder, or with an Irex
System II ultrasound unit with either a 2.25 or 3.5 MHz
transducer. M-mode echocardiograms obtained at the time
of the initial and the most recent clinical assessment were
analyzed. Measurements of left ventricular end-diastolic di-
mension and ventricular septal and posterior wall thickness
were obtained at the peak of the R wave of the electrocar-
diogram, using the leading-edge method (8). Wall thickness
and cavity dimension were assessed either at the mitral valve
level or just distal to the mitral valve leaflets, at whichever
point septal thickness was maximal. Each pair of echocar-
diograms was coded and measurements were obtained by
one observer who had no knowledge of the identity of the
patients.
Statistical methods. Data were expressed as mean ±
SO. Differences between means were determined using the
Student's paired t test.
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Results
Two-dimensional echocardiographic findings. None
of the 65 study patients showed an increase (2:5 mm) in
thickness of any of the left ventricular segments between
the initial and the most recent two-dimensional echocardio-
graphic evaluation. In contrast, 9 (14%) of the 65 patients
showed a substantial decrease (2:5 mm) in wall thickness
in at least one left ventricular segment (Fig. 2); in these 9
patients, the left ventricular segments that showed the max-
imal change decreased from 21 :±: 5 to 15 ::t 4 mm (range
5 to 9 mm). Wall thinning most commonly involved the
anterior ventricular septum (7 patients), but also occurred
in the posterior ventricular septum (6 patients), lateral free
wall (2 patients) and posterior free wall (I patient).
M-mode echocardiographic findings. M-mode echo-
cardiography was utilized to assess the changes in thickness
of the anterior ventricular septum (the only portion of the
septum visualized by M-mode echocardiography) and in the
size of the left ventricular cavity. Thickness of the anterior
septum decreased significantly (from 23 :±: 3 to 15 ± 2
mm; p < 0.00 I) in the seven patients with thinning of that
region on two-dimensional echocardiography. Furthermore.
left ventricular end-diastolicdiameter increased significantly
(from 44 ± 6 to 51 ± 6 mm; p < 0.001) in the overall
group of nine patients with thinning of the septum or the
free wall on two-dimensional echocardiography. However.
although left ventricular cavity dimension increased signif-
icantly, it remained within normal limits (:5:52 mm) (9) in
seven of these nine patients; in the other two, the end-
diastolic cavity dimension was 60 and 63 mm, respectively.
In the 56 study patients without evidence of changes in
left ventricular wall thickness on two-dimensional echo-
cardiography, septal thickness (measured by M-modeecho-
cardiography) remained unchanged between the initial (20
± 6 mm) and the most recent (20 ± 6 mm) examination.
In these patients. a small but statistically signifi cant increase
in left ventricular end-diastolic diameter was identified be-
tween the initial (42 ± 5 mm) and the most recent (43 ±
5 mrn; p < 0.0 I) examination.
Clinical findings. Of the nine patients who showed left
ventricular wall thinning, seven were < 40 years of age
(range 27 to 39, mean 32), and the other two were 45 and
48 years old. respectively. In these two older patients, the
presence of associated coronary artery disease had been
excluded by coronary arteriography. Significant left ven-
tricular outflow obstruction under basal conditions (gradient
2:30 mm Hg) was absent in each of the nine patients with
left ventricular wall thinning. Eight of the nine patients were
severely symptomatic at the most recent evaluation. Three
of these eight had only mild symptoms (New York Heart
Association functional class II) at the initial evaluation, but
showed marked symptomatic deterioration (to functional
class IV) during the follow-up period; one of these patients
died of congestive heart failure. and the other two experi-
enced severe heart failure and ultimately underwent cardiac
Figure 2. Stop-frames of two-dimen-
sional echocardiograms, obtained in
the parasternal long-axis view during
diastole , showing thinning of the an-
terior ventricular septum (VS) in a pa-
tient with nonobstructive hypertrophic
cardiomyopathy. A, Septal thickness
is 32 mm at age 32. 8, Two years
later, septal thickness has clearly de-
creased (to 17 mm). The echocardio-
grams are accompanied by drawings
shown to the right (calibration dots
or marks are 10 mm apart). Ao =
aorta; LA = left atrium; LV = left
ventricle ; MV = mitral valve.
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transplantation. Of the remaining five patients who were
severely symptomatic at the most recent evaluation, each
had marked functional limitation (functional class III or IV)
throughout the follow-up period and two died of congestive
heart failure.
Of the 56 study patients who did not show changes in
left ventricular wall thickness, 43 were asymptomatic or
only mildly symptomatic and 13 were severely symptomatic
at the most recent evaluation. Forty of these 56 patients
experienced no significant change in clinical condition dur-
ing the follow-up period; 9 showed symptomatic deterio-
ration and 7 showed improvement (by at least one functional
class). Left ventricular outflow obstruction under basal con-
ditions (gradient ~30 mm Hg) was present in 12 (21%) of
these 56 patients.
Discussion
Progression of leftventricular hypertrophy. Our pres-
ent echocardiographic findings suggest that left ventricular
wall thickness does not increase substantially during adult-
hood in patients with hypertrophic cardiomyopathy. None
of our 65 adult patients showed an increase in wall thickness
of ~5 mm in any region of the left ventricle during a 3 to
6 year follow-up period. These findings are in striking con-
trast to those of our previous investigation (I), which iden-
tified marked progression of left ventricular hypertrophy
(mean increase in wall thickness of > 100%) in a large
proportion of a study group of children with hypertrophic
cardiomyopathy, followed up over a similar period. Hence,
those previous observations in conjunction with the results
of the present investigation suggest that progression of left
ventricular hypertrophy in hypertrophic cardiomyopathy is
largely confined to childhood.
Our current findings differ somewhat from those of 00-
menicucci et al. (10), who described progression of left
ventricular hypertrophy in 4 of 39 adult patients with hy-
pertrophic cardiomyopathy. The reason for the discrepancy
between these two studies is unclear. However, Oomeni-
cucci et al. (10) provided quantitative data regarding wall
thickness in just one patient, a subject who showed an in-
crease in posterior wall thickness of only 3 mm. Therefore,
the changes in wall thickness identified by these investi-
gators were apparently mild and may have been within the
potential error of the echocardiographic technique.
Limitations. Certain limitations of our study should be
pointed out. We have arbitrarily defined progression of hy-
pertrophy as a change in wall thickness of at least 5 mm.
This cutoff value was selected in consideration of the image
resolution limitations of two-dimensional echocardiography
(II) and to minimize false positive diagnosis of wall thick-
ening. Conversely, the 5 mm cutoff value may have pro-
hibited us from identifying minor increases in wall thickness
that could have occurred in our patients. Nevertheless, al-
though it is possible that some of our adult patients expe-
rienced a mild increase in left ventricular wall thickness,
they certainly did not show the striking progression of left
ventricular hypertrophy that we (I) previously observed in
children with hypertrophic cardiomyopathy. We should also
emphasize that although our study group of 65 patients with
hypertrophic cardiomyopathy studied with serial echocardi-
ography over a period of 3 to 6 years is relatively large, we
cannot extrapolate from these findings that substantial pro-
gression of left ventricular hypertrophy never occurs in adult
patients with hypertrophic cardiomyopathy. Nevertheless,
our results suggest that, if such progression does occur, it
must be very uncommon. Also, we do not know whether
the features of hypertrophic cardiomyopathy can develop
during adulthood in individuals who previously had a mor-
phologically normal heart, because all our study patients
were initially selected on the basis of having echocardio-
graphic evidence of hypertrophic cardiomyopathy.
Left ventricular wall thinning. Although we did not
identify progression of left ventricular hypertrophy in our
adult patients with hypertrophic cardiomyopathy, about 10%
of the study patients showed another important change in
left ventricular morphology, that is a significant decrease
(of ~5 mm) in left ventricular wall thickness. This wall
thinning involved various regions of the left ventricle, but
was most common in the anterior and posterior portions of
the ventricular septum. In these patients with left ventricular
wall thinning, end-diastolic cavity dimension increased sub-
stantially during follow-up (from 44 to 51 mm); however,
in most of these patients, absolute end-diastolic cavity di-
mension remained within normal limits. These changes in
left ventricular morphology were usually associated with
severe and progressive cardiac symptoms; indeed, eight of
the nine patients who showed wall thinning developed
congestive heart failure, including five who either died or
underwent cardiac transplantation. These observations are
in agreement with recent findings from our laboratory (12,13)
showing that progressive wall thinning and relative increase
in left ventricular cavity dimension are not uncommon in
severely symptomatic patients with hypertrophic cardio-
myopathy.
Previous investigations have described, in a relatively
small number of patients, the evolution of "typical" hy-
pertrophic cardiomyopathy (that is, hypertrophied and non-
dilated) into a phase morphologically and functionally re-
sembling a dilated cardiomyopathy (14-21). Conversely,
most of the patients with left ventricular wall thinning and
progressive cavity enlargement identified in our investiga-
tion still showed left ventricular hypertrophy and a cavity
dimension within normal limits at the most recent evalua-
tion. Thus, the progressive changes in left ventricular mor-
phology that occurred in about 10% of our study patients
could only be identified by comparing serial echocardio-
graphic studies. For this reason, we believe that the true
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frequency with which such changes in wall thickness and
cavity size occur in symptomatic patients with hypertrophic
cardiomyopathy may have been previously underestimated.
Conclusions. The resultsof our studyof 65 adultpatients
with hypertrophic cardiomyopathy, together with our pre-
vious findings in children, suggest that although substantial
progression of left ventricular hypertrophy may occur in
patients with hypertrophic cardiomyopathy during child-
hood, such increasesin wall thicknessdo not appearto occur
during adult life. Conversely, left ventricularwall thickness
may decrease in a significant minority of adults with hy-
pertrophic cardiomyopathy, and these changes are usually
associated with relative left ventricular cavity enlargement
and severe clinical deterioration.
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